List of Tables
Table 1. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Global Cell Therapy and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2020-2025)
Table 8. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2026-2031)
Table 10. Cell Therapy and Gene Therapy CDMO Market Trends
Table 11. Cell Therapy and Gene Therapy CDMO Market Drivers
Table 12. Cell Therapy and Gene Therapy CDMO Market Challenges
Table 13. Cell Therapy and Gene Therapy CDMO Market Restraints
Table 14. Global Cell Therapy and Gene Therapy CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell Therapy and Gene Therapy CDMO Market Share by Players (2020-2025)
Table 16. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2024)
Table 17. Ranking of Global Top Cell Therapy and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell Therapy and Gene Therapy CDMO, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy and Gene Therapy CDMO, Product and Application
Table 21. Global Key Players of Cell Therapy and Gene Therapy CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Pharmaceuticals Company Details
Table 47. Lonza Pharmaceuticals Business Overview
Table 48. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product
Table 49. Lonza Pharmaceuticals Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 50. Lonza Pharmaceuticals Recent Development
Table 51. Thermo Fisher Company Details
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product
Table 54. Thermo Fisher Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Recent Development
Table 56. catalent Company Details
Table 57. catalent Business Overview
Table 58. catalent Cell Therapy and Gene Therapy CDMO Product
Table 59. catalent Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 60. catalent Recent Development
Table 61. Jubilant LifeSciences Company Details
Table 62. Jubilant LifeSciences Business Overview
Table 63. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product
Table 64. Jubilant LifeSciences Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 65. Jubilant LifeSciences Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product
Table 69. Boehringer Ingelheim Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Oxford BioMedica Company Details
Table 72. Oxford BioMedica Business Overview
Table 73. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product
Table 74. Oxford BioMedica Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 75. Oxford BioMedica Recent Development
Table 76. Charles River Company Details
Table 77. Charles River Business Overview
Table 78. Charles River Cell Therapy and Gene Therapy CDMO Product
Table 79. Charles River Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 80. Charles River Recent Development
Table 81. WuXi AppTec Company Details
Table 82. WuXi AppTec Business Overview
Table 83. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product
Table 84. WuXi AppTec Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 85. WuXi AppTec Recent Development
Table 86. He Yuan Biology Company Details
Table 87. He Yuan Biology Business Overview
Table 88. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product
Table 89. He Yuan Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 90. He Yuan Biology Recent Development
Table 91. GenScript Biotech Company Details
Table 92. GenScript Biotech Business Overview
Table 93. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product
Table 94. GenScript Biotech Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 95. GenScript Biotech Recent Development
Table 96. Kanglong Chemical Company Details
Table 97. Kanglong Chemical Business Overview
Table 98. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product
Table 99. Kanglong Chemical Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 100. Kanglong Chemical Recent Development
Table 101. Porton shares Company Details
Table 102. Porton shares Business Overview
Table 103. Porton shares Cell Therapy and Gene Therapy CDMO Product
Table 104. Porton shares Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 105. Porton shares Recent Development
Table 106. Sano Biologics Company Details
Table 107. Sano Biologics Business Overview
Table 108. Sano Biologics Cell Therapy and Gene Therapy CDMO Product
Table 109. Sano Biologics Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 110. Sano Biologics Recent Development
Table 111. Yunzhou Biology Company Details
Table 112. Yunzhou Biology Business Overview
Table 113. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product
Table 114. Yunzhou Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 115. Yunzhou Biology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cell Therapy and Gene Therapy CDMO Picture
Figure 2. Global Cell Therapy and Gene Therapy CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell Therapy and Gene Therapy CDMO Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Gene Therapy Features
Figure 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell Therapy and Gene Therapy CDMO Market Share by Application: 2024 VS 2031
Figure 8. Clinical Stage Projects Case Studies
Figure 9. Commercialization Stage Projects Case Studies
Figure 10. Cell Therapy and Gene Therapy CDMO Report Years Considered
Figure 11. Global Cell Therapy and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cell Therapy and Gene Therapy CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cell Therapy and Gene Therapy CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Cell Therapy and Gene Therapy CDMO Market Share by Players in 2024
Figure 15. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2024
Figure 17. North America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 19. United States Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 23. Germany Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Share by Region (2020-2031)
Figure 31. China Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Lonza Pharmaceuticals Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 47. Thermo Fisher Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 48. catalent Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 49. Jubilant LifeSciences Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 51. Oxford BioMedica Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 52. Charles River Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 53. WuXi AppTec Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 54. He Yuan Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 55. GenScript Biotech Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 56. Kanglong Chemical Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 57. Porton shares Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 58. Sano Biologics Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 59. Yunzhou Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
